The average one-year price target for Opus Genetics (NasdaqCM:IRD) has been revised to $9.73 / share. This is an increase of 23.44% from the prior estimate of $7.88 dated February 21, 2026. The price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results